Paper Details

  1. Home
  2. Paper Details

4-Methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells.

Author: ByrneAgustín, FrancoPaula G, HajosSilvia E, LompardíaSilvina L, PibuelMatías A, PoodtsDaniela, SiasSofía A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Glioblastoma (GBM) is a deadly brain tumor with a poor prognosis. This study evaluated the effects of 4-methylumbelliferone (4MU) in combination with temozolomide (TMZ) or vincristine (VCR) in human GBM cells. 4MU was found to sensitize GBM cells to both TMZ and VCR and to inhibit cell proliferation and metabolic activity. These results suggest that 4MU may be a potential therapeutic alternative for GBM treatment, including in patients with TMZ-resistant disease.
Paper Details　
Original Abstract of the Article :
Glioblastoma (GBM) is the most frequent malignant primary tumor of the CNS in adults, with a median survival of 14.6 months after diagnosis. The effectiveness of GBM therapies remains poor, highlighting the need for new therapeutic alternatives. In this work, we evaluated the effect of 4-methylumbel...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249561/

データ提供：米国国立医学図書館（NLM）

Enhancing Chemotherapy Effectiveness with 4-Methylumbelliferone

The field of [Glioblastoma] research is constantly searching for new and more effective treatments for this aggressive form of [Brain Cancer]. This study investigates the potential of [4-Methylumbelliferone (4MU)], a [Coumarin Derivative] with no reported adverse effects, to enhance the effectiveness of [Chemotherapy] in treating [Glioblastoma]. The researchers found that [4MU] significantly enhanced the effects of both [Temozolomide (TMZ)] and [Vincristine (VCR)] in both [Temozolomide-Sensitive] and [Temozolomide-Resistant] [Glioblastoma Cells].

A Potential New Strategy for Glioblastoma Treatment

The study demonstrates that [4MU] can effectively enhance the efficacy of [Chemotherapy] in treating [Glioblastoma]. This finding suggests that [4MU] could be a valuable tool for improving [Glioblastoma] treatment, particularly in cases of [Temozolomide Resistance]. The researchers also observed that [4MU] inhibited [Metabolic Activity] and [Cell Proliferation] in [Glioblastoma Cells].

Exploring New Avenues for Glioblastoma Treatment

This research opens up exciting new avenues for [Glioblastoma] treatment. It's like discovering a hidden oasis in the vast and challenging desert of [Brain Cancer] research. By exploring new combinations of drugs and therapies, we can find more effective ways to fight this devastating disease. This study provides a compelling case for further research into the potential of [4MU] as a [Chemotherapeutic Adjuvant] for [Glioblastoma].

Dr.Camel's Conclusion

The study suggests that 4MU is a potential therapeutic alternative for improving GBM therapy even on TMZ-refractory patients. This finding could have important implications for the treatment of glioblastoma, particularly in cases of temozolomide resistance.

Date :
  1. Date Completed 2023-06-12
  2. Date Revised 2023-11-21
Further Info :

Pubmed ID

37291120

DOI: Digital Object Identifier

PMC10249561

Related Literature

Article Analysis
・Effects of temozolomide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.